Company Filing History:
Years Active: 2017
Title: Amanda L. Whiting: Innovator in Ubiquitin Research
Introduction
Amanda L. Whiting is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of biomedical research, particularly in the development of peptide inhibitors targeting the linear ubiquitin chain assembly complex (LUBAC). Her work is crucial for advancing treatments for various diseases.
Latest Patents
Amanda holds a patent for "Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods." This invention focuses on peptide inhibitors of LUBAC and outlines methods for treating diseases such as activated B-cell like diffuse large B cell lymphoma (ABC DLBCL) and autoimmune or inflammatory disorders. She has 1 patent to her name.
Career Highlights
Amanda is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to engage in cutting-edge research that has the potential to impact patient care and treatment options significantly.
Collaborations
Amanda has collaborated with notable researchers in her field, including Louis M. Staudt and Yibin Yang. These partnerships enhance the scope and impact of her research endeavors.
Conclusion
Amanda L. Whiting is a dedicated inventor whose work in the field of ubiquitin research is paving the way for innovative treatments for serious health conditions. Her contributions are vital to the ongoing advancements in medical science.